Greenphire, a provider of payment technologies for the clinical trials industry, has expanded into the European market with the opening of its London office. This addition is a key part of the 2013 strategic plan and is designed to support the increasing global demand for Greenphire’s products and services.

The expansion reflects the commercial and operational success Greenphire has enjoyed in the last two years. Both global payment technology platforms for patient and investigator payments have seen increased adoption within the life sciences industry and the new office in London will play a critical role in continuing to build on the growth Greenphire has experienced.

“We are excited to execute on this key part of our 2013 strategic plan,” said Sam Whitaker, founder and CEO of Greenphire. “Establishing our presence in Europe allows us to support our enterprise clients in those areas where they conduct research and development, facilitates stronger support of the many clinical investigators conducting research on behalf of biopharmaceutical companies and provides a base from which we can grow our commercial presence in Europe.”